Back to Trades
Grant4
INCYTE CORP
INCY
Total Value
$1.3M
Company Information
- Company Name
- INCYTE CORP
- Ticker Symbol
- INCY
- CIK
- 0000879169
Insider Information
- Role
- EVP, Head of US Oncology
- Location
- WILMINGTON, DE
Officer
Filing Details
- Filing Date
- Jul 17, 2025
- Transaction Date
- Jul 15, 2025
- Accession Number
- 0000879169-25-000090
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 15, 2025 | Common Stock | 8,769 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 15, 2025 | Derivative | 21,923 | — | Grant/Award | — |
| Jul 15, 2025 | Derivative | 19,735 | $68.25 | Grant/Award | $1.3M |
Footnotes
- (F1)Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- (F2)Including the July 15, 2025 grant, this includes an aggregate of 85,252 shares of common stock issuable pursuant to previously reported RSUs that have not vested.
- (F3)Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
- (F4)The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.